Pharma Stocks Gain Momentum: Lupin, Aurobindo Pharma, Medanta & Apollo In Focus
2026-10-01 16:31:24Pharma Stocks Gain Momentum: Lupin, Aurobindo Pharma, Medanta & Apollo In Focus Business Today...
Read MorePharma Stocks Gain Momentum: Lupin, Aurobindo Pharma, Medanta & Apollo In Focus
2026-10-01 16:31:24Pharma Stocks Gain Momentum: Lupin, Aurobindo Pharma, Medanta & Apollo In Focus Business Today...
Read MoreGST appellate authority upholds 4.6 crore ITC claim order against Aurobindo Pharma
2026-09-30 08:34:49GST appellate authority upholds 4.6 crore ITC claim order against Aurobindo Pharma thehindubusinessline.com...
Read MoreSun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speci
2026-09-29 08:56:22Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speci The Economic Times...
Read MoreJM Financial sees up to 28% upside in Dr Reddys and Aurobindo Pharma. Should you buy?
2026-09-16 14:39:55JM Financial sees up to 28% upside in Dr Reddys and Aurobindo Pharma. Should you buy? The Economic Times...
Read MoreAurobindo Pharma gets USFDA approval for generic inhalation aerosol for asthma patients
2026-09-15 16:06:01Aurobindo Pharma gets USFDA approval for generic inhalation aerosol for asthma patients BusinessLine...
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
05-Oct-2026 | Source : BSESubmission of certificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended September 30 2026.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
03-Oct-2026 | Source : BSESubmission of Press Release that is being issued by the Company in connection with receipt of USFDA final approval for Perampanel Tablets 2 mg 4 mg 6 mg 8 mg 10 mg and 12 mg.
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015.
02-Oct-2026 | Source : BSEIntimation of completion of acquisition.
Corporate Actions
No Upcoming Board Meetings
Aurobindo Pharma Ltd. has declared 400% dividend, ex-date: 08 Aug 25
Aurobindo Pharma Ltd. has announced 1:5 stock split, ex-date: 10 Feb 11
Aurobindo Pharma Ltd. has announced 1:1 bonus issue, ex-date: 20 Jul 15
No Rights history available